Moxifloxacin + Betamethasone in pharma franchise in Assam

Moxifloxacin + Betamethasone in PCD pharma franchise in Lucknow

Moxifloxacin + Betamethasone in top pharma company in Chennai

Moxifloxacin + Betamethasone in phama franchise company in India

Moxifloxacin + Betamethasone in pcd pharma supplier in Kolkata
Moxifloxacin + Betamethasone in phama distributor in Surat

Home/Products /moxifloxacin-5-w-v-betamethasone-0-point-1-w-v-ear-drops

Moxolunic B Ear Drop

Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)

Dosage Form : Ear Drops

Packaging Type : Dropper

Packaging : 5ml

Price : ₹120/-

Moxolunic B Ear Drop is a combination of Moxifloxacin (5% w/v), a powerful antibiotic, and Betamethasone (0.1% w/v), a corticosteroid with anti-inflammatory properties. This dual-action formula is specifically designed to treat bacterial ear infections and associated inflammation effectively.

Moxifloxacin belongs to the fluoroquinolone class of antibiotics and works by inhibiting the bacterial enzymes necessary for DNA replication, thereby halting bacterial growth and eradicating the infection. Betamethasone complements this action by reducing inflammation, swelling, redness, and itching in the ear, promoting faster relief and healing.

This ear drop is particularly effective in treating otitis externa (commonly known as swimmer’s ear) and other bacterial infections of the external ear. The easy-to-use dropper allows for precise application, ensuring that the medication reaches the affected area directly for maximum efficacy.

By combining the antibacterial and anti-inflammatory properties, Moxolunic B Ear Drop not only addresses the infection but also alleviates discomfort, making it a reliable solution for ear-related bacterial conditions. Regular use as prescribed can prevent complications and promote overall ear health.

Read More

About the Product

Moxolunic B Ear Drop is a combination of Moxifloxacin (5% w/v), a powerful antibiotic, and Betamethasone (0.1% w/v), a corticosteroid with anti-inflammatory properties. This dual-action formula is specifically designed to treat bacterial ear infections and associated inflammation effectively.

Moxifloxacin belongs to the fluoroquinolone class of antibiotics and works by inhibiting the bacterial enzymes necessary for DNA replication, thereby halting bacterial growth and eradicating the infection. Betamethasone complements this action by reducing inflammation, swelling, redness, and itching in the ear, promoting faster relief and healing.

This ear drop is particularly effective in treating otitis externa (commonly known as swimmer’s ear) and other bacterial infections of the external ear. The easy-to-use dropper allows for precise application, ensuring that the medication reaches the affected area directly for maximum efficacy.

By combining the antibacterial and anti-inflammatory properties, Moxolunic B Ear Drop not only addresses the infection but also alleviates discomfort, making it a reliable solution for ear-related bacterial conditions. Regular use as prescribed can prevent complications and promote overall ear health.

Possible side effects include mild irritation, stinging, or itching at the application site. If symptoms persist or worsen, consult a healthcare professional.

Indicated for bacterial infections of the ear, including otitis externa, and to relieve associated inflammation and discomfort.

For external ear use only. Use strictly as prescribed by a doctor. Avoid contact with eyes and discontinue use if severe irritation or allergic reactions occur.

Store in a cool, dry place below 25°C. Keep the bottle tightly closed and away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation